DN
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Incidence and Risk Factors for Infection in Heart Transplant Recipients on Posttransplant Extracorporeal Membrane Oxygenation (ECMO) | Transplantation direct |  | 2025 | 4 | 14 | ||
| Comparing variable and feature selection strategies for prediction - protocol of a simulation study in low-dimensional transplantation data | PloS one | | 2025 | 13 | 27 | ||
| Old Pathogens-New Patient Types : Infections in a CAR T-Cell Recipient. Could It Get Any More Complicated ? | Transplant infectious disease | | 2025 | 6 | 13 | ||
| The Importance of MRI in the Early Diagnosis of Acute Invasive Fungal Rhinosinusitis | Diagnostics | | 2025 | 153 | 120 | ||
| Blood virome after allogeneic hematopoietic stem cell transplantation | Open forum infectious diseases | | 2025 | 54 | 73 | ||
| Empirical and targeted antimicrobial therapy in patients with febrile neutropenia and haematological malignancy or after haematopoietic cell transplantation : recommendations from the 10th European Conference on Infections in Leukaemia | The Lancet Infectious Diseases |  | 2025 | 5 | 0 | ||
| Isolation measures during the COVID-19 pandemic in transplant units may decrease respiratory infection rates and improve non-relapse mortality | Bone marrow transplantation | | 2025 | 5 | 0 | ||
| Pneumonia definition in allogeneic hematopoietic cell transplant recipients : Update and challenges in 2024. Recommendations from the EBMT Infectious Diseases Working Party and Practice Harmonization and Guidelines committee | Current research in translational medicine | | 2025 | 7 | 11 | ||
| Invasive Candida infections in solid organ transplant recipients between 2008 and 2020 | American Journal of Transplantation | | 2025 | 12 | 15 | ||
| Breakthrough Invasive Mould Infections Under Posaconazole Prophylaxis in Patients With Haematologic Malignancies : A Case-Control Study | Mycoses | | 2025 | 5 | 18 | ||
| Management of Clostridioides difficile infection in patients with haematological malignancies and after cellular therapy : guidelines from 10th European Conference on Infections in Leukaemia (ECIL - 10) | EClinicalMedicine | | 2025 | 4 | 19 | ||
| Population pharmacokinetic analysis of letermovir in adult hematopoietic cell transplant recipients | Antimicrobial agents and chemotherapy | | 2025 | 6 | 10 | ||
| Surgical site infections, risk factors, and outcomes after liver transplant | JAMA network open | | 2025 | 71 | 151 | ||
| Epidemiology of resistant bacterial infections in patients with hematological malignancies or undergoing hematopoietic cell transplantation in Europe : A systematic review by the European Conference on Infections in Leukemia (ECIL) | The Journal of infection | | 2025 | 4 | 17 | ||
| Management of Invasive Pulmonary Aspergillosis in Intensive Care Units : Guidelines From the Fungal Infection Network of Switzerland (FUNGINOS) | Mycoses | | 2025 | 6 | 102 | ||
| Epidemiology of hospital-acquired bloodstream infections in haemato-oncology patients in Geneva, Switzerland | Infection | | 2025 | 36 | 119 | ||
| Antifungal treatment duration in hematology patients with invasive mold infections : a real-life update | Open forum infectious diseases | | 2024 | 89 | 74 | ||
| Refractory/Resistant Cytomegalovirus Infection in Transplant Recipients : An Update | Viruses | | 2024 | 4 | 15 | ||
| Effectiveness, Safety, and Patterns of Real-World Isavuconazole Use in Europe (2015–2019) | Infectious diseases and therapy | | 2024 | 6 | 21 | ||
| Reexploring cytomegalovirus serology in allogeneic hematopoietic cell transplantation | Current opinion in infectious diseases | | 2024 | 105 | 105 | ||
| Isavuconazole for the Treatment of Fungal Infections : A Real-life Experience From the Fungal Infection Network of Switzerland (FUNGINOS) | Open forum infectious diseases | | 2024 | 81 | 158 | ||
| An Update on Breakthrough Invasive Mold Infections | Mycopathologia | | 2024 | 5 | 9 | ||
| Current practice of screening and antimicrobial prophylaxis to prevent Gram-negative bacterial infection in high-risk haematology patients : results from a pan-European survey | Therapeutic advances in infectious disease | | 2024 | 4 | 7 | ||
| Clinicopathologic conference : Bloodstream infection in an allogeneic hamatopoietic cell transplant : Thinking beyond the usual | Transplant infectious disease | | 2024 | 31 | 53 | ||
| Do infectious diseases after kidney retransplantation differ from those after first kidney transplantation ? | Open forum infectious diseases | | 2024 | 112 | 84 | ||
| Pitfalls in Valganciclovir Prophylaxis Dose Adjustment Based on Renal Function in Kidney Transplant Recipients | Transplant international | | 2024 | 110 | 95 | ||
| BK polyomavirus serotype-specific antibody responses in blood donors and kidney transplant recipients with and without new-onset BK polyomavirus-DNAemia : A Swiss Transplant Cohort Study | American journal of transplantation | | 2024 | 45 | 81 | ||
| Adjunctive glucocorticoid therapy for Pneumocystis jirovecii pneumonia in solid organ transplant recipients : A multicenter cohort, 2015-2020 | American journal of transplantation | | 2024 | 28 | 18 | ||
| Surgical site infections after kidney transplantation are independently associated with graft loss | American journal of transplantation | | 2024 | 56 | 141 | ||
| Frequency and impact on renal transplant outcomes of urinary tract infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species | Frontiers in medicine | | 2024 | 86 | 24 | ||
| Pre-engraftment bacteremia after allogeneic hematopoietic cell transplantation without primary fluoroquinolone antibacterial prophylaxis | Transplant infectious disease | | 2024 | 62 | 111 | ||
| Bacterial infections in solid organ transplant recipients | Current opinion in organ transplantation | | 2024 | 25 | 1 | ||
| Epidemiology, outcomes and risk factors for recurrence of Clostridioides difficile infections following allogeneic hematopoietic cell transplantation : a longitudinal retrospective multicenter study | Bone marrow transplantation | | 2024 | 78 | 56 | ||
| How I treat : Coronavirus disease 2019 in leukemic patients and hematopoietic cell transplant recipients | Transplant infectious disease | | 2024 | 6 | 9 | ||
| Pitfalls in definitions on respiratory viruses and particularities of Adenovirus infection in hematopoietic cell transplantation patients : Recommendations from the EBMT practice harmonization and guidelines committee | Current research in translational medicine | | 2024 | 52 | 63 | ||
| Invasive aspergillosis in liver transplant recipients in the current era | American journal of transplantation | | 2024 | 20 | 0 | ||
| Routine infectious disease consultation prior to an allogeneic hematopoietic cell transplant | Open forum infectious diseases | | 2023 | 81 | 97 | ||
| Comparing the Real-World Use of Isavuconazole to Other Anti-Fungal Therapy for Invasive Fungal Infections in Patients with and without Underlying Disparities : A Multi-Center Retrospective Study | Journal of Fungi | | 2023 | 93 | 129 | ||
| 'Which trial do we need ? Culture of preservation fluid in abdominal organ transplant recipients' Author's reply | Clinical microbiology and infection | | 2023 | 5 | 15 | ||
| Vaccine-preventable infections among solid organ transplant recipients in Switzerland | JAMA network open | | 2023 | 134 | 135 | ||
| Revisiting cytomegalovirus serology in allogeneic hematopoietic cell transplant recipients | Clinical infectious diseases | | 2023 | 101 | 125 | ||
| Antifungal prophylaxis and pre-emptive therapy : when and how ? | Molecular aspects of medicine | | 2023 | 82 | 44 | ||
| Which trial do we need ? Culture of preservation fluid in abdominal organ transplant recipients | Clinical microbiology and infection | | 2023 | 5 | 4 | ||
| Duration of antifungal treatment in mold infection : when is enough ? | Current opinion in infectious diseases | | 2023 | 88 | 17 | ||
| The present and future of blood virome in allogeneic hematopoietic cell transplant recipients | Current opinion in infectious diseases | | 2023 | 93 | 95 | ||
| Bloodstream infections in allogeneic haematopoietic cell recipients from the swiss transplant cohort study: trends of causative pathogens and resistance rates | Bone marrow transplantation | | 2023 | 150 | 74 | ||
| American Society for Transplantation and Cellular Therapy Series, #6 : Management of Invasive Candidiasis in Hematopoietic Cell Transplantation Recipients | Transplantation and cellular therapy | | 2023 | 79 | 93 | ||
| CMV Infection After Letermovir Primary Prophylaxis Discontinuation in Allogeneic Hematopoietic Cell Transplant Recipients | Open forum infectious diseases | | 2023 | 138 | 65 | ||
| Immunogenicity of High-Dose vs. MF59-adjuvanted vs. Standard Influenza Vaccine in Solid Organ Transplant Recipients : The STOP-FLU trial | Clinical infectious diseases | | 2023 | 104 | 98 | ||
| Immune monitoring-guided vs fixed duration of antiviral prophylaxis against cytomegalovirus in solid-organ transplant recipients. A Multicenter, Randomized Clinical Trial | Clinical infectious diseases | | 2023 | 146 | 176 | ||
| Invasive Aspergillosis and the Impact of Azole-resistance | Current fungal infection reports | | 2023 | 67 | 126 | ||
| Longitudinal Detection of Twenty DNA and RNA Viruses in Allogeneic Hematopoietic Stem Cell Transplant Recipients Plasma | Viruses | | 2023 | 152 | 109 | ||
| Bacteremia During the First Year After Solid Organ Transplantation : An Epidemiological Update | Open forum infectious diseases | | 2023 | 125 | 96 | ||
| Salvage Treatment of Refractory HSV Oral Lesions with Pritelivir in Allogeneic Hematopoietic Cell Transplant Recipients | Antimicrobial agents and chemotherapy | | 2023 | 103 | 281 | ||
| Hepatitis E Virus Infection Epidemiology in Recipients of Allogeneic Hematopoietic Cell Transplant | Open forum infectious diseases | | 2023 | 67 | 86 | ||
| Nouveautés dans la prise en charge de l’infection à cytomégalovirus chez les patients transplantés | Revue médicale suisse | | 2023 | 94 | 36 | ||
| Invasive Mold Infections in Allogeneic Hematopoietic Cell Transplant Recipients in 2020: Have We Made Enough Progress? | Open forum infectious diseases | | 2022 | 269 | 194 | ||
| Central nervous system infections in solid organ transplant recipients: Results from the Swiss Transplant Cohort Study | The Journal of infection | | 2022 | 255 | 184 | ||
| Friends and foes : “The quarrels of friends are the opportunities of foes” | Current opinion in infectious diseases | | 2022 | 6 | 0 | ||
| Atypical pulmonary phaeohyphomycosis due to Aureobasidium spp. - case report and brief literature review | Swiss medical weekly | | 2022 | 182 | 75 | ||
| Distribution of Aspergillus Species and Prevalence of Azole Resistance in Respiratory Samples From Swiss Tertiary Care Hospitals | Open forum infectious diseases | | 2022 | 234 | 160 | ||
| Therapeutic Drug Monitoring of Orally Administered Letermovir Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplant Recipients | Antimicrobial agents and chemotherapy | | 2022 | 101 | 240 | ||
| Frequency and causes of antifungal treatment changes in allogeneic haematopoïetic cell transplant recipients with invasive mould infections | Mycoses | | 2022 | 301 | 181 | ||
| Impact of different urinary tract infection phenotypes within the first year post-transplant on renal allograft outcomes | American journal of transplantation | | 2022 | 187 | 116 | ||
| Letermovir for cytomegalovirus primary prophylaxis in a multiple abdominal/small bowel transplant recipient | Clinical transplantation | | 2022 | 255 | 0 | ||
| Epidemiology and outcomes of bone and joint infections in solid organ transplant recipients | American journal of transplantation | | 2022 | 241 | 115 | ||
| T cell receptor sequencing reveals reduced clonal breadth of T-cell responses against SARS-CoV-2 after natural infection and vaccination in allogeneic hematopoietic stem cell transplant recipients | Annals of oncology | | 2022 | 259 | 103 | ||
| When and how do we stop antifungal treatment for an invasive mould infection in allogeneic haematopoietic cell transplant recipients? | Mycoses | | 2022 | 100 | 61 | ||
| Surgical site infections after simultaneous pancreas kidney and pancreas transplantation in the Swiss Transplant Cohort Study | Journal of hospital infection | | 2022 | 250 | 116 | ||
| Epidemiology and outcomes of medically attended and microbiologically confirmed bacterial foodborne infections in solid organ transplant recipients | American journal of transplantation | | 2022 | 211 | 109 | ||
| Screening for Parasitic Infection and Tuberculosis in Immunosuppressed and Pre-Immunosuppressed Patients: An Observational Study | Tropical medicine and infectious disease | | 2021 | 242 | 190 | ||
| COVID-19-associated pulmonary aspergillosis (CAPA): how big a problem is it? | Clinical microbiology and infection | | 2021 | 234 | 137 | ||
| Progress and current challenges in the management of invasive fungal infections in hematologic malignancy patients and allogeneic hematopoietic cell transplant recipients | | 2021 | 337 | 487 | |||
| Letermovir Primary Prophylaxis in High-Risk Hematopoietic Cell Transplant Recipients: A Matched Cohort Study | Vaccines | | 2021 | 204 | 251 | ||
| Association of antiviral prophylaxis and rituximab use with posttransplant lymphoproliferative disorders (PTLDs): A nationwide cohort study | American journal of transplantation | | 2021 | 279 | 167 | ||
| Predictors of breakthrough clinically significant cytomegalovirus infection during letermovir prophylaxis in high-risk hematopoietic cell transplant recipients | Immunity, inflammation and disease | | 2021 | 372 | 176 | ||
| Temporal trends, risk factors and outcomes of infections due to extended-spectrum β-lactamase producing Enterobacterales in Swiss solid organ transplant recipients between 2012 and 2018 | Antimicrobial resistance and infection control | | 2021 | 380 | 129 | ||
| Burden, epidemiology, and outcomes of microbiologically confirmed respiratory viral infections in solid organ transplant recipients: a nationwide, multi-season prospective cohort study | American journal of transplantation | | 2021 | 150 | 113 | ||
| Clinical considerations of isavuconazole administration in high-risk hematological patients: a single-center 5-year experience | Mycopathologia | | 2021 | 243 | 194 | ||
| Clinical considerations on posaconazole administration and therapeutic drug monitoring in allogeneic hematopoietic cell transplant recipients | Medical mycology | | 2021 | 358 | 1 | ||
| Invasive aspergillosis in solid organ transplant patients: diagnosis, prophylaxis, treatment, and assessment of response | BMC infectious diseases | | 2021 | 156 | 228 | ||
| Differences between infectious disease events in first liver transplant versus retransplantation in the Swiss Transplant Cohort Study | Liver transplantation | | 2021 | 142 | 0 | ||
| Editorial: Transplant infectious disease landscape in the COVID19-Era | Current opinion in infectious diseases | | 2021 | 193 | 0 | ||
| The EHA research roadmap: infections in hematology | HemaSphere | | 2021 | 230 | 186 | ||
| Clinical and Pharmacological Considerations for Concomitant Administration of Posaconazole and Isavuconazole with Letermovir | Antimicrobial agents and chemotherapy | | 2021 | 249 | 402 | ||
| Trends of the Epidemiology of Candidemia in Switzerland: A 15-Year FUNGINOS Survey | Open forum infectious diseases | | 2021 | 104 | 104 | ||
| Real-life considerations on antifungal treatment combinations for the management of invasive mold infections after allogeneic cell transplantation | Journal of Fungi | | 2021 | 188 | 142 | ||
| Safety and efficacy of intravenously administered cidofovir in adult haematopoietic cell transplant recipients: a retrospective multicentre cohort study | The journal of antimicrobial chemotherapy | | 2021 | 212 | 0 | ||
| Efficacy and safety of isavuconazole compared with voriconazole as primary antifungal prophylaxis in allogeneic hematopoietic cell transplant recipients | Medical mycology | | 2021 | 166 | 0 | ||
| Invasive aspergillosis due to Aspergillus section Usti: a multicenter retrospective study | Clinical Infectious Diseases | | 2020 | 252 | 633 | ||
| Risk factors for candidemia: a prospective matched case-control study | Critical Care | | 2020 | 381 | 174 | ||
| Response to "Missed diagnosis and misdiagnosis of infectious diseases in hematopoietic cell transplant recipients: an autopsy study" | Blood advances | | 2020 | 203 | 60 | ||
| Emerging echinocandin-resistant Candida albicans and glabrata in Switzerland | Infection | | 2020 | 246 | 177 | ||
| First experience of SARS-CoV-2 infections in solid organ transplant recipients in the Swiss Transplant Cohort Study | American Journal of Transplantation | | 2020 | 293 | 135 | ||
| Intracellular Pathogen in the Cerebrospinal Fluid of an Allogeneic Hematopoietic Cell Transplant Recipient With Graft-Versus-Host Disease and Brain Lesions | Clinical infectious diseases | | 2020 | 273 | 0 | ||
| Reasons for voriconazole prophylaxis discontinuation in allogeneic hematopoietic cell transplant recipients: A real-life paradigm | Medical Mycology | | 2020 | 222 | 287 | ||
| Optimal treatment duration of pseudomonas aeruginosa infections in allogeneic hematopoietic cell transplant recipients | Open Forum Infectious Diseases | | 2020 | 462 | 135 | ||
| First case of Cryptococcus gattii multilobar pneumonia in Switzerland and associated challenges | Swiss Medical Weekly | | 2020 | 383 | 154 | ||
| Combination treatment with letermovir and ganciclovir for maintenance therapy of multidrug-resistant CMV infection in a liver transplant recipient | Transplantation | | 2020 | 347 | 1 | ||
| Microbiologically documented infections after adult allogeneic hematopoietic cell transplantation: A 5-year analysis within the Swiss Transplant Cohort study | Transplant Infectious Disease | | 2020 | 404 | 2 | ||
| Prophylaxie antimicrobienne et approches thérapeutiques empiriques et préemptives pour la prévention des infections chez les receveurs de greffe allogénique de cellules hématopoïétiques | | 2020 | 535 | 238 | |||
| Infectiologie sur mesure - 1. Immunogénétique des maladies infectieuses : premiers pas | Revue médicale suisse | | 2019 | 297 | 4 | ||
| National point prevalence survey on healthcare-associated infections in acute care hospitals, Switzerland, 2017 | Euro Surveillance | | 2019 | 375 | 232 | ||
| Antimicrobial prophylaxis and preemptive approaches for the prevention of infections in the stem cell transplant recipient, with analogies to the hematologic malignancy patient | Infectious disease clinics of North America | | 2019 | 177 | 381 | ||
| Epidemiology, risk factors and outcomes of invasive aspergillosis in solid organ transplant recipients in the Swiss Transplant Cohort Study | Transplant Infectious Disease | | 2018 | 590 | 0 | ||
| Pentraxin-3 polymorphisms and invasive mold infections in acute leukemia patients receiving intensive chemotherapy | Haematologica | | 2018 | 251 | 181 | ||
| Accuracy of Sensititre YeastOne echinocandins epidemiological cut-off values for identification of FKS mutant Candida albicans and Candida glabrata: a ten year national survey of the Fungal Infection Network of Switzerland (FUNGINOS) | Clinical Microbiology and Infection | | 2018 | 326 | 222 | ||
| Efficacy of brincidofovir as prophylaxis against HSV and VZV in hematopoietic cell transplant recipients | Transplant Infectious Disease | | 2018 | 331 | 162 | ||
| Incidence and outcome of invasive fungal diseases after allogeneic hematopoietic stem cell transplantation: A Swiss transplant cohort study | Transplant Infectious Disease | | 2018 | 470 | 0 | ||
| Pneumocystis jirovecii pneumonia in solid organ transplant recipients: a descriptive analysis for the Swiss Transplant Cohort | Transplant Infectious Disease | | 2018 | 382 | 1 | ||
| First case of Candida auris in Switzerland: discussion about preventive strategies | Swiss Medical Weekly | | 2018 | 506 | 280 |
